« Back
Home /
Eudesmin

Eudesmin

Item no.	TMO-T3836-50mg
Manufacturer	TargetMol
CASRN	526-06-7
Amount	50 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Cell Biology Cytoskeleton Reagents & Chemicals Intermediate filaments Molecules
Type	Molecules
Specific against	other
Purity	99.92%
Citations	Cho J Y , Yoo E S , Baik K U , et al. Eudesmin inhibits tumor necrosis factor-alpha production and T cell proliferation[J]. Archives of Pharmacal Research, 1999, 22(4):348-353.
Smiles	[H][C@@]12CO[C@@]([H])(c3ccc(OC)c(OC)c3)[C@]1([H])CO[C@@]2([H])c1ccc(OC)c(OC)c1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	526-06-7
Shipping Condition	Cool pack
Available
Manufacturer - Targets	MAPK\|\|\|S6 Kinase
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	386.44
Description	Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways.
Pathways	MAPK\|\|\|PI3K/Akt/mTOR signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3836-50mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question